Showing results (11-20 of 16) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Human Vaccines|February 28, 2009
Priming of CD4+ and CD8+ T cell responses using a HCV core ISCOMATRIX vaccine: a phase I study in healthy volunteersDebbie Drane, Eugene Maraskovsky, Rebecca Gibson, et al.Vaccine|May 27, 2004
ISCOM based vaccines for cancer immunotherapyAleksandra Lenarczyk, Thuy T T Le, Debbie Drane, et al.Vaccine|August 19, 2004
ISCOMATRIX adjuvant: an adjuvant suitable for use in anticancer vaccinesTrina J Stewart, Debbie Drane, Jim Malliaros, et al.Blood|November 18, 2004
Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen deliveryMax Schnurr, Qiyuan Chen, Amanda Shin, et al.Immunology and Cell Biology|September 7, 2011
ISCOMATRIX vaccines mediate CD8+ T-cell cross-priming by a MyD88-dependent signaling pathwayNicholas S Wilson, Becky Yang, Adriana Baz Morelli, et al.Journal of Virology|May 30, 2008
Induction of broad CD4+ and CD8+ T-cell responses and cross-neutralizing antibodies against hepatitis C virus by vaccination with Th1-adjuvanted polypeptides followed by defective alphaviral particles expressing envelope glycoproteins gpE1 and gpE2 and nonstructural proteins 3, 4, and 5Yinling Lin, Taewoo Kwon, John Polo, et al.Pageof 2